These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28738455)

  • 1. [Cost-effectiveness and affordability of strategy for preventing mother-to-child transmission of hepatitis B in China].
    Lin Y; Zhang SX; Yang PC; Cai YL; Zou YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):852-859. PubMed ID: 28738455
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cost-effectiveness of community-based treatment of chronic hepatitis B in China].
    Zhang SX; Yang PC; Cai YL; Lin Y; Zou YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):860-867. PubMed ID: 28738456
    [No Abstract]   [Full Text] [Related]  

  • 3. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
    Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cost-effectiveness and cost-benefit analysis on strategy for preventing mother-to-child transmission of hepatitis B virus].
    Cai YL; Zhang SX; Yang PC; Lin Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jun; 37(6):846-51. PubMed ID: 27346114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-benefit analysis of the hepatitis B vaccination to prevent mother-to-child transmission strategies in China, 1992-2019].
    Zheng H; Wang FZ; Zhang GM; Miao N; Liang XF; Yin ZD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Sep; 42(9):1537-1545. PubMed ID: 34814581
    [No Abstract]   [Full Text] [Related]  

  • 6. [Economic evaluation and prediction of hepatitis B immunization strategy in Shenzhen, China].
    Sun PP; Zhang SX; Xia Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):743-747. PubMed ID: 29996303
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of economic outcomes of "hepatitis B vaccine event reported by media" in China, 2013].
    Zhang SX; Sun PP; Xia Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Aug; 52(8):837-841. PubMed ID: 30107719
    [No Abstract]   [Full Text] [Related]  

  • 8. [Survey of economic burden of hepatitis B-related diseases in 12 areas in China].
    Ma QS; Liang S; Xiao HW; Zhang SX; Zhuang GH; Zou YH; Tan HZ; Liu JC; Zhang YH; Xu AQ; Zhang L; Feng XX; Hu DS; Wang FZ; Cui FQ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):868-876. PubMed ID: 28738457
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-vaccination serologic testing of infants born to hepatitis B surface antigen-positive mothers is more cost-effective in Zhejiang Province, China: A Markov chain analysis.
    Lu Z; Zhou Y; Yan R; Deng X; Tang X; Zhu Y; Xu X; Zheng W; He H
    J Viral Hepat; 2022 Apr; 29(4):280-288. PubMed ID: 35075747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-effectiveness of HIV self-testing strategy in men who have sex with men].
    Huang SZ; Dai WC; Li XF; Jiang XH; Tang WM; Zhou Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):753-757. PubMed ID: 32447920
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness analysis of the national Perinatal Hepatitis B Prevention Program.
    Barbosa C; Smith EA; Hoerger TJ; Fenlon N; Schillie SF; Bradley C; Murphy TV
    Pediatrics; 2014 Feb; 133(2):243-53. PubMed ID: 24394684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection.
    Hung HF; Chen HH
    Pharmacoeconomics; 2011 Dec; 29(12):1063-73. PubMed ID: 22077578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study on the health economic evaluations of prevention of mother-to-child HIV transmission in Dehong prefecture, Yunnan province, China from 2004 to 2013].
    Shan D; Wang J; Duan S; Guo Y; Tang S; Yang Y; Ye R; Xue H; Zhang G; Hu Y; Sun J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jun; 49(6):490-5. PubMed ID: 26310332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness Analysis of Hepatitis B Immunization in Vietnam: Application of Cost-Effectiveness Affordability Curves in Health Care Decision Making.
    Tu HAT; de Vries R; Woerdenbag HJ; Li SC; Le HH; van Hulst M; Postma MJ
    Value Health Reg Issues; 2012 May; 1(1):7-14. PubMed ID: 29702830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of couple-based immunization strategy to prevent mother-to-child transmission of hepatitis B virus in China: A decision-analytic Markov model.
    Jing W; Liu J; Wu Y; Ma Q; Liu M
    EClinicalMedicine; 2020 Feb; 19():100264. PubMed ID: 32055793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost-effectiveness of HCV testing strategies for hepatitis C elimination in general population in China].
    Liu PC; Xu D; Ding GW; Zhao L; Yu JJ; Liu ZF; Li J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Mar; 45(3):464-472. PubMed ID: 38514325
    [No Abstract]   [Full Text] [Related]  

  • 17. The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis.
    Yin J; Ji Z; Liang P; Wu Q; Cui F; Wang F; Liang X; Zhuang G
    Vaccine; 2015 Jul; 33(31):3731-8. PubMed ID: 26057138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic implications of entecavir treatment in suppressing viral replication in chronic hepatitis B (CHB) patients in China from a perspective of the Chinese Social Security program.
    Yuan Y; Iloeje U; Li H; Hay J; Yao GB
    Value Health; 2008 Mar; 11 Suppl 1():S11-22. PubMed ID: 18387054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the national hepatitis B immunization program in China: a modeling study.
    Liu Z; Li M; Hutton DW; Wagner AL; Yao Y; Zhu W; Cao L; Tang S; Pan J; Wang Y; Zhao Q; Ren H; Wang Y; Wang W
    Infect Dis Poverty; 2022 Oct; 11(1):106. PubMed ID: 36221140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of option B+ in prevention of mother-to-child transmission of HIV in Yunnan Province, China.
    Wang X; Guo G; Zheng J; Lu L
    BMC Infect Dis; 2019 Jun; 19(1):517. PubMed ID: 31185927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.